Clinical Trial: FDA-Approved CBD Formulation Reduces Post-Operative Opioid Consumption Following Knee Replacement Surgery
"Patients receiving 400mg CBD had lower post-operative opioid consumption, reduced pain scores at rest and with movement, and fewer rescue analgesic interventions."The post Clinical Trial: FDA-Approved CBD Formulation Reduces Post-Operative Opioid Consumption Following Knee Replacement Surgery appeared first on NORML. Go to the article